Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
31.78
-0.49 (-1.53%)
May 14, 2025, 2:59 PM - Market open
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
$991,093
Profits / Employee
$91,861
Market Cap
1.78B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SUPN News
- 7 days ago - Supernus Pharmaceuticals, Inc. (SUPN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Supernus Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 20 days ago - Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 - GlobeNewsWire
- 2 months ago - Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Supernus to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Supernus Pharmaceuticals, Inc. (SUPN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Supernus Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation - GlobeNewsWire